The top 100 stock
market authors
selected for publication
market authors
selected for publication
-
Vitamin Beats Statin: Is Merck's Zetia in Trouble?
Today - Friday, November 20th
-
King Pharma Marches Higher
-
BioMed News Bytes: AstraZeneca, Delcath, Unilife
-
Pfizer Is Best Positioned Big Pharma in China - Goldman
-
A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
-
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
-
Competition in Blood - Thinners: Win - Win for Everyone Involved
-
Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows
Thursday, November 19th
-
NeurogesX: Next Stop, U.S. Market
-
Genzyme's Problems Continue with Discontinuation of Kidney Drug Development
-
Oral-lyn vs. Afresa: How Generex Will Beat Mannkind
-
J&J vs. 10-Year T-Bonds: The Power of Rising Dividends
-
Biotech Stocks for a Possible Year-End Rally
Wednesday, November 18th
-
Poniard Pharmaceuticals' Gamble Doesn't Pay Off
-
Billionaire Validation (x2): Barnes & Noble, Forest Labs
-
BioMed News Bytes: GeoVax, Cerus, Discovery Labs, NeurogesX
-
Titan Pharmaceuticals: Finally Reaching Its Potential
Tuesday, November 17th
-
AOB's Cash Generation Provides Backstop to Earnings Miss
-
Will Questions over Cholestorol Drug Zetia Create a Major Setback for Merck?
-
Genzyme: Key Pipeline Setback Continues Negative Sentiment
-
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
-
Genzyme: Haunted by Contamination
Monday, November 16th
-
Progenics: Are the Prospects That Bad?
-
Another Manufacturing Setback for Genzyme
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most active
Instabloggers.-
1
David Fry
-
2
TraderMark
-
3
Don Dion
-
4
Cliff Wachtel
-
5
Mike Havrilla
Top Instabloggers » -
1
-
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
